{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:39:15Z","timestamp":1762979955635},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/bjc.2012.547","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T13:37:03Z","timestamp":1357738623000},"page":"866-872","source":"Crossref","is-referenced-by-count":29,"title":["A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial"],"prefix":"10.1038","volume":"108","author":[{"given":"E","family":"Provenzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-L","family":"Vallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Champ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Walland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Grier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Iddawela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Earl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"BFbjc2012547_CR1","first-page":"419","volume-title":"In Cancer Staging Handbook from the AJCC Cancer Staging Manual","author":"SB Edge","year":"2010","unstructured":"AJCC (2010) Breast. In Cancer Staging Handbook from the AJCC Cancer Staging Manual Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) 7th edn pp 419\u2013460. Springer: New York"},{"key":"BFbjc2012547_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2559.1996.d01-485.x","volume":"29","author":"F Aktepe","year":"1996","unstructured":"Aktepe F, Kapucuoglu N, Pak I (1996) The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology 29: 63\u201367","journal-title":"Histopathology"},{"key":"BFbjc2012547_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.soc.2010.04.001","volume":"19","author":"HD Bear","year":"2010","unstructured":"Bear HD (2010) Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy. Surg Oncol Clin N Am 19: 607\u2013626","journal-title":"Surg Oncol Clin N Am"},{"key":"BFbjc2012547_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jncimonographs\/lgr037","volume":"2011","author":"A Berruti","year":"2011","unstructured":"Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G, Aglietta M, Gianni L, Miller WR, Untch M, Sotiriou C, Daidone M, Conte P, Kennedy D, Damia G, Petronini P, Di Cosimo S, Bruzzi P, Dowsett M, Desmedt C, Mansel RE, Olivetti L, Tondini C, Sapino A, Fenaroli P, Tortora G, Thorne H, Bertolini F, Ferrozzi F, Danova M, Tagliabue E, de Azambuja E, Makris A, Tampellini M, Dontu G, Van't Veer L, Harris AL, Fox SB, Dogliotti L, Bottini A (2011) International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer. Cremona, Italy (2010). J Natl Cancer Inst Monogr 2011: 147\u2013151","journal-title":"Cremona, Italy (2010). J Natl Cancer Inst Monogr"},{"key":"BFbjc2012547_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jnci\/82.19.1539","volume":"82","author":"G Bonadonna","year":"1990","unstructured":"Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, Bartoli C, Coopmans de Yoldi G, Zucali R, Rilke F (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539\u20131545","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2012547_CR6","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/cncr.23083","volume":"110","author":"AU Buzdar","year":"2007","unstructured":"Buzdar AU (2007) Preoperative chemotherapy treatment of breast cancer--a review. Cancer 110: 2394\u20132407","journal-title":"Cancer"},{"key":"BFbjc2012547_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/jnci\/dji206","volume":"97","author":"LA Carey","year":"2005","unstructured":"Carey LA, Metzger R, Dees EC, Collichio F, Sartor CI, Ollila DW, Klauber-DeMore N, Halle J, Sawyer L, Moore DT, Graham ML (2005) American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J Natl Cancer Inst 97: 1137\u20131142","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2012547_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00000421-199306000-00006","volume":"16","author":"B Chevallier","year":"1993","unstructured":"Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P (1993) Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 16: 223\u2013228","journal-title":"Am J Clin Oncol"},{"key":"BFbjc2012547_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/sj.bjc.6601258","volume":"89","author":"P Chollet","year":"2003","unstructured":"Chollet P, Amat S, Belembaogo E, Cure H, de Latour M, Dauplat J, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Penault-Llorca F (2003) Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer? Br J Cancer 89: 1185\u20131191","journal-title":"Br J Cancer"},{"key":"BFbjc2012547_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1634\/theoncologist.2007-0107","volume":"13","author":"S Dawood","year":"2008","unstructured":"Dawood S, Broglio K, Kau SW, Islam R, Symmans WF, Buchholz TA, McGuire SE, Meric-Bernstam F, Cristofanilli M, Hortobagyi GN, Gonzalez-Angulo AM (2008) Prognostic value of initial clinical disease stage after achieving pathological complete response. Oncologist 13: 6\u201315","journal-title":"Oncologist"},{"key":"BFbjc2012547_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/annonc\/mdq345","volume":"22","author":"S Dawood","year":"2011","unstructured":"Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22: 515\u2013523","journal-title":"Ann Oncol"},{"issue":"Suppl 3","key":"BFbjc2012547_CR12","first-page":"S15","volume":"11","author":"M Dowsett","year":"2009","unstructured":"Dowsett M, A'Hern R, Salter J, Zabaglo L, Smith IE (2009) Who would have thought a single Ki67 measurement would predict long-term outcome? Breast Cancer Res 11 (Suppl 3): S15","journal-title":"Breast Cancer Res"},{"key":"BFbjc2012547_CR13","doi-asserted-by":"crossref","unstructured":"Earl H, Vallier A-L, Hillier L, Fenwick N, Iddawela M, Hughes-Davies L, Provenzano E, McAdam K, Hickish T, Caldas C (2009) Neo-tAnGo: A neoadjuvant randomised phase III trial of epirubicin\/cyclophosphamide (EC) and paclitaxel (T)\u00b1gemcitabine (G) in the treatment of women with high-risk early breast cancer (EBC): First report of the primary endpoint - pathological complete response (pCR). J Clin Oncol 27 (Suppl 15): abstract 522; poster presentation","DOI":"10.1200\/jco.2009.27.15_suppl.522"},{"key":"BFbjc2012547_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jncimonographs\/lgr030","volume":"2011","author":"D Generali","year":"2011","unstructured":"Generali D, Symmans WF, Berruti A, Fox SB (2011) Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 2011: 99\u2013102","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"BFbjc2012547_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10549-011-1454-x","volume":"127","author":"I Gounaris","year":"2011","unstructured":"Gounaris I, Britton P, Taylor K, Wallis M, Hiller L, Vallier A-L, Provenzano E, Iddawela M, Earl H, Sinnatamby R (2011) Accuracy of uni-dimensional and volumetric measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat 127 (2): 459\u2013469","journal-title":"Breast Cancer Res Treat"},{"key":"BFbjc2012547_CR16","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","volume":"23","author":"BT Hennessy","year":"2005","unstructured":"Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU, Kau SW, Fornage B, Sahin A, Broglio K, Singletary SE, Valero V (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23: 9304\u20139311","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","volume":"250","author":"KK Hunt","year":"2009","unstructured":"Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250: 558\u2013566","journal-title":"Ann Surg"},{"issue":"1","key":"BFbjc2012547_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PRS.0b013e3181da8699","volume":"126","author":"A Ismail","year":"2010","unstructured":"Ismail A, Azzawi K, Farouhi P, Earl H, Malata CM (2010) Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction: a retrospective comparison. Plast Reconstr Surg 126 (1): 1\u201311","journal-title":"Plast Reconstr Surg"},{"key":"BFbjc2012547_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.bjc.6602950","volume":"94","author":"RL Jones","year":"2006","unstructured":"Jones RL, Lakhani SR, Ring AE, Ashley S, Walsh G, Smith IE (2006) Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma. Br J Cancer 94: 358\u2013362","journal-title":"Br J Cancer"},{"key":"BFbjc2012547_CR20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cncr.24173","volume":"115","author":"A Loya","year":"2009","unstructured":"Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA (2009) Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer 115: 1605\u20131612","journal-title":"Cancer"},{"key":"BFbjc2012547_CR21","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, Bear HD, Caldwell CB, Walker AP, Mikkelson WM, Stauffer JS, Robidoux A, Theoret H, Soran A, Fisher B, Wickerham DL, Wolmark N (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23: 2694\u20132702","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jncimonographs\/lgr025","volume":"2011","author":"C Marchio","year":"2011","unstructured":"Marchio C, Sapino A (2011) The pathologic complete response open question in primary therapy. J Natl Cancer Inst Monogr 2011: 86\u201390","journal-title":"J Natl Cancer Inst Monogr"},{"key":"BFbjc2012547_CR23","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1200\/JCO.2006.08.2271","volume":"25","author":"C Mazouni","year":"2007","unstructured":"Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L (2007) Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. J Clin Oncol 25: 2650\u20132655","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR24","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","volume":"14","author":"EA Newman","year":"2007","unstructured":"Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA (2007) Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14: 2946\u20132952","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2012547_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, Schofield A, Heys SD (2003) A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 12: 320\u2013327","journal-title":"Breast"},{"key":"BFbjc2012547_CR26","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/cncr.23068","volume":"110","author":"JL Oh","year":"2007","unstructured":"Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110: 2420\u20132427","journal-title":"Cancer"},{"key":"BFbjc2012547_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jso.21128","volume":"98","author":"MZ Papa","year":"2008","unstructured":"Papa MZ, Zippel D, Kaufman B, Shimon-Paluch S, Yosepovich A, Oberman B, Sadetzki S (2008) Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol 98: 403\u2013406","journal-title":"J Surg Oncol"},{"key":"BFbjc2012547_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.humpath.2007.11.019","volume":"39","author":"F Penault-Llorca","year":"2008","unstructured":"Penault-Llorca F, Abrial C, Raoelfils I, Cayre A, Mouret-Reynier MA, Leheurteur M, Durando X, Achard JL, Gimbergues P, Chollet P (2008) Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer. Hum Pathol 39: 1221\u20131228","journal-title":"Hum Pathol"},{"key":"BFbjc2012547_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2559.2006.02419.x","volume":"50","author":"SE Pinder","year":"2007","unstructured":"Pinder SE, Provenzano E, Earl H, Ellis IO (2007) Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology 50: 409\u2013417","journal-title":"Histopathology"},{"key":"BFbjc2012547_CR30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N (2008) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26: 778\u2013785","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","volume":"20","author":"R Rouzier","year":"2002","unstructured":"Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E (2002) Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20: 1304\u20131310","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5858\/133.4.633","volume":"133","author":"S Sahoo","year":"2009","unstructured":"Sahoo S, Lester SC (2009) Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med 133: 633\u2013642","journal-title":"Arch Pathol Lab Med"},{"key":"BFbjc2012547_CR33","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1245\/s10434-009-0612-4","volume":"16","author":"M Sakakibara","year":"2009","unstructured":"Sakakibara M, Nagashima T, Kadowaki M, Onai Y, Fujimori T, Yokomizo J, Suzuki H, Fushimi K, Nakatani Y, Miyazaki M (2009) Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastases. Ann Surg Oncol 16: 2470\u20132478","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2012547_CR34","first-page":"297","volume":"180","author":"DM Sataloff","year":"1995","unstructured":"Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 180: 297\u2013306","journal-title":"J Am Coll Surg"},{"key":"BFbjc2012547_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00595-010-4404-z","volume":"41","author":"K Shimazu","year":"2011","unstructured":"Shimazu K, Noguchi S (2011) Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer. Surg Today 41: 311\u2013316","journal-title":"Surg Today"},{"key":"BFbjc2012547_CR36","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1200\/JCO.2002.20.6.1456","volume":"20","author":"IC Smith","year":"2002","unstructured":"Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, Ah-See AK, Eremin O, Walker LG, Sarkar TK, Eggleton SP, Ogston KN (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20: 1456\u20131466","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR37","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25: 4414\u20134422","journal-title":"J Clin Oncol"},{"key":"BFbjc2012547_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/jnci\/djn085","volume":"100","author":"G von Minckwitz","year":"2008","unstructured":"von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, Gerber B, Huober J, Costa SD, Jackisch C, Loibl S, Mehta K, Kaufmann M (2008) Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst 100: 542\u2013551","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2012547_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","volume":"30","author":"N Wolmark","year":"2001","unstructured":"Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30: 96\u2013102","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012547","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:12:11Z","timestamp":1684415531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFbjc2012547"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.547","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]}}}